Evidence map›Paper›PMID 36562299›Full record

ArticleCirculation research2023

NDRG1 Signaling Is Essential for Endothelial Inflammation and Vascular Remodeling.

Guanxin Zhang, Qing Qin, Chen Zhang, Xiaobo Sun, Kyosuke Kazama, Bing Yi, Fang Cheng, Zhi-Fu Guo, Jianxin Sun

Open access · bronzeAbstract read
In one paragraph

Article in Circulation research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
4.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. ETS‑1/ETS‑2 transcription factors in CVD (Review).International journal of molecular medicine · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Guanxin Zhang *Center for Translational Medicine, Thomas Jefferson University, Philadelphia, PA (G.Z., Q.Q., C.Z., X.S., K.K., B.Y., F.C., Z.-F.G., J.S.).
Qing Qin *Center for Translational Medicine, Thomas Jefferson University, Philadelphia, PA (G.Z., Q.Q., C.Z., X.S., K.K., B.Y., F.C., Z.-F.G., J.S.).
Chen Zhang *Center for Translational Medicine, Thomas Jefferson University, Philadelphia, PA (G.Z., Q.Q., C.Z., X.S., K.K., B.Y., F.C., Z.-F.G., J.S.).
Xiaobo SunCenter for Translational Medicine, Thomas Jefferson University, Philadelphia, PA (G.Z., Q.Q., C.Z., X.S., K.K., B.Y., F.C., Z.-F.G., J.S.).
Kyosuke KazamaCenter for Translational Medicine, Thomas Jefferson University, Philadelphia, PA (G.Z., Q.Q., C.Z., X.S., K.K., B.Y., F.C., Z.-F.G., J.S.).
Bing YiCenter for Translational Medicine, Thomas Jefferson University, Philadelphia, PA (G.Z., Q.Q., C.Z., X.S., K.K., B.Y., F.C., Z.-F.G., J.S.).
Fang ChengCenter for Translational Medicine, Thomas Jefferson University, Philadelphia, PA (G.Z., Q.Q., C.Z., X.S., K.K., B.Y., F.C., Z.-F.G., J.S.).
Zhi-Fu GuoCenter for Translational Medicine, Thomas Jefferson University, Philadelphia, PA (G.Z., Q.Q., C.Z., X.S., K.K., B.Y., F.C., Z.-F.G., J.S.).ORCID 0000-0003-2730-818X
Jianxin SunCenter for Translational Medicine, Thomas Jefferson University, Philadelphia, PA (G.Z., Q.Q., C.Z., X.S., K.K., B.Y., F.C., Z.-F.G., J.S.).ORCID 0000-0001-5319-912X
Thomas Jefferson University · US

Funding

Targeting Latexin Signaling for Endothelial Barrier Dysfunction in Inflammatory Lung InjuryR01HL152703 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI SUMMER, ROSS S, SUN, JIANXIN · 2021 to 2024
$2.8M
Prevention of anthracycline-induced cardiotoxicity by Nur77 activationR01HL159168 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI SUN, JIANXIN · 2021 to 2024
$2.1M
NHLBI NIH HHS R01 HL152703NHLBI NIH HHS R01 HL159168
6 · The paper itself

Abstract

backgroundNDRG-1 (N-myc downstream-regulated gene 1) is a member of NDRG family that plays essential roles in cell differentiation, proliferation, and stress responses. Although the expression of NDRG1 is regulated by fluid shear stress, its roles in vascular biology remain poorly understood. The purpose of the study is to determine the functional significance of NDRG1 in vascular inflammation and remodeling. METHODS AND

resultsBy using quantitative polymerase chain reaction, western blot, and immunohistochemistry, we demonstrate that the expression of NDRG1 is markedly increased in cytokine-stimulated endothelial cells and in human and mouse atherosclerotic lesions. To determine the role of NDRG1 in endothelial activation, we performed loss-of-function studies using NDRG1 short hairpin RNA. Our results demonstrate that NDRG1 knockdown by lentivirus bearing NDRG1 short hairpin RNA substantially attenuates both IL-1β (interleukin-1β) and TNF-α (tumor necrosis factor-α)-induced expression of cytokines/chemokines and adhesion molecules. Intriguingly, inhibition of NDRG1 also significantly attenuates the expression of procoagulant molecules, such as PAI-1 (plasminogen activator inhibitor type 1) and TF (tissue factor), and increases the expression of TM (thrombomodulin) and t-PA (tissue-type plasminogen activator), thus exerting potent antithrombotic effects in endothelial cells. Mechanistically, we showed that NDRG1 interacts with orphan Nur77 (nuclear receptor) and functionally inhibits the transcriptional activity of Nur77 and NF-κB (nuclear factor Kappa B) in endothelial cells. Moreover, in NDRG1 knockdown cells, both cytokine-induced mitogen-activated protein kinase activation, c-Jun phosphorylation, and AP-1 (activator protein 1) transcriptional activity are substantially inhibited. Neointima and atherosclerosis formation induced by carotid artery ligation and arterial thrombosis were markedly attenuated in endothelial cell-specific NDRG1 knockout mice compared with their wild-type littermates.

conclusionsOur results for the first time identify NDRG1 as a critical mediator implicated in regulating endothelial inflammation, thrombotic responses, and vascular remodeling, and suggest that inhibition of NDRG1 may represent a novel therapeutic strategy for inflammatory vascular diseases, such as atherothrombosis and restenosis.

Indexed as

Endothelial CellsThrombosisAnimalsCytokinesHumansInflammationMiceNF-kappa BRNA, Small InterferingTumor Necrosis Factor-alphaVascular RemodelingCytokinesNF-kappa BRNA, Small InterferingTumor Necrosis Factor-alphaAP-1, Nur77endothelial cellsinflammationNDRG1NF-κB

Identifiers

PMID36562299
PMCPMC9898177
OpenAlexW4312100873

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.